Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04188808 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Case-control Study in Patients With PAA

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 1, 2022 (before its estimated January 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 2023 to Jan 2024v4
  2. Lead sponsor: Iva Jergovic to Rebecka Hultgrenv3
  3. Site contacts updated at 1 of 2 sites
    • Study description shortened, about 1 word
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall objective is to highlight different aspects of care in patients with PAA before and after treatment, and identifying factors that influence the outcome of PAA patients.
Trial Details
NCT Number NCT04188808
Lead Sponsor Rebecka Hultgren
Collaborators: Karolinska University Hospital, Karolinska Institutet, Stockholm South General Hospital, Sahlgrenska University Hospital
Conditions
(from sponsor)		 Popliteal Artery Aneurysm, Peripheral Arterial Disease, Quality of Life
Related terms Peripheral Arterial Disease, Popliteal Artery Aneurysm, Vascular Diseases
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov